Sarif Biomedical sues medical device company Accuray for patent infringement over the latter's CyberKnife cancer treatment device.

Sarif Biomedical accused Accuray (NSDQ:ARAY) of infringing 1 of its patents with the CyberKnife radiosurgery device for cancer, which uses targeted radiation blasts to destroy tumor cells.
Tool, Texas-based Sarif's patent covers ""Computer-Assisted Microsurgery Methods and Equipment." The medical device company alleges that Accuray's device trespasses on that intellectual property, according to the lawsuit.
The FDA's Orthopedic & Rehabilitations Devices Panel agrees with the FDA's recommendations that...
Medical device company Edwards Lifesciences unveils 1-year results for its next-generation Sapien XT...
A federal judge overseeing a raft of cases filed against Johnson & Johnson's DePuy Orthopaedics...
Medical device giant Boston Scientific touts very low rates of paravalvular leakage in 30-day results...
Efforts to undermine the medical device tax are "narrow-minded and dishonest" attempts to win "...